Evan Bayh in the Wall Street Journal in late September tells the story of the damage to jobs and innovation that is caused by the President’s 2.3% tax on medical devices. Layoffs are being planned, R&D budgets are being slashed and corporations are considering moving as we move closer to implementation. Bayh argues that Congress must act to avoid this catastrophe.

Read more.